| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| 2024 | 2023 | CARE.COACH CORPORATION | 199 CALIFORNIA DR | MILLBRAE | CA | 94030-3118 | SAN MATEO | USA | SB1AG082634 | A State-of-the-Art Automatic Speech Recognition and Conversational Platform to Enable Socially Assistive Robots for Persons with Alzheimer's Disease and Related Dementias | 000 | 1 | NIH | 12/12/2023 | $0 |
| 2024 | 2021 | CARE.COACH CORPORATION | 199 CALIFORNIA DR | MILLBRAE | CA | 94030-3118 | SAN MATEO | USA | R44AG062014 | A Specialized Automatic Speech Recognition and Conversational Platform to Enable Socially Assistive Robots for Persons with Mild-to-Moderate Alzheimer's Disease and Related Dementia | 000 | 3 | NIH | 1/23/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $2,206,826 ) |
| 2023 | 2023 | CARE.COACH CORPORATION | 199 CALIFORNIA DR | MILLBRAE | CA | 94030-3118 | SAN MATEO | USA | R44AG085913 | Implementing and Scaling the STEADI Fall Prevention Algorithm Using a Conversational Relational Agent for Community-Dwelling Older Adults with and without Mild Cognitive Impairment (MCI). | 000 | 1 | NIH | 9/25/2023 | $544,163 |
| 2023 | 2023 | CARE.COACH CORPORATION | 199 CALIFORNIA DR | MILLBRAE | CA | 94030-3118 | SAN MATEO | USA | R44CA236253 | A Bedside Relational Agent to Improve Hematopoietic Cell Transplantation Outcomes in Cancer Patients | 000 | 2 | NIH | 8/21/2023 | $364,580 |
| 2023 | 2023 | CARE.COACH CORPORATION | 199 CALIFORNIA DR | MILLBRAE | CA | 94030-3118 | SAN MATEO | USA | SB1AG082634 | A State-of-the-Art Automatic Speech Recognition and Conversational Platform to Enable Socially Assistive Robots for Persons with Alzheimer's Disease and Related Dementias | 000 | 1 | NIH | 4/26/2023 | $1,298,083 |
| 2023 | 2020 | CARE.COACH CORPORATION | 199 CALIFORNIA DR | MILLBRAE | CA | 94030-3118 | SAN MATEO | USA | R44NR017842 | A Protocol-Driven, Digital Conversational Agent at the Hospital Bedside to Support Nurse Teams and to Mitigate Delirium and Falls Risk | 000 | 3 | NIH | 5/30/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| 2022 | 2021 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44AG062014 | A Specialized Automatic Speech Recognition and Conversational Platform to Enable Socially Assistive Robots for Persons with Mild-to-Moderate Alzheimer's Disease and Related Dementia | 000 | 3 | NIH | 10/20/2021 | $0 |
| 2022 | 2020 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44NR017842 | A Protocol-Driven, Digital Conversational Agent at the Hospital Bedside to Support Nurse Teams and to Mitigate Delirium and Falls Risk | 000 | 3 | NIH | 1/5/2022 | $0 |
| 2022 | 2019 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44CA236253 | A Bedside Relational Agent to Improve Hematopoietic Cell Transplantation Outcomes in Cancer Patients | 000 | 1 | NIH | 3/29/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,386,676 ) |
| 2021 | 2021 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44AG062014 | A Specialized Automatic Speech Recognition and Conversational Platform to Enable Socially Assistive Robots for Persons with Mild-to-Moderate Alzheimer's Disease and Related Dementia | 002 | 3 | NIH | 7/30/2021 | $1,386,676 |
| 2021 | 2020 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44AG062014 | A Specialized Automatic Speech Recognition and Conversational Platform to Enable Socially Assistive Robots for Persons with Mild-to-Moderate Alzheimer's Disease and Related Dementia | 000 | 2 | NIH | 12/8/2020 | $0 |
| 2021 | 2020 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44NR017842 | A Protocol-Driven, Digital Conversational Agent at the Hospital Bedside to Support Nurse Teams and to Mitigate Delirium and Falls Risk | 001 | 3 | NIH | 3/19/2021 | $0 |
| 2021 | 2019 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44CA236253 | A Bedside Relational Agent to Improve Hematopoietic Cell Transplantation Outcomes in Cancer Patients | 000 | 1 | NIH | 4/5/2021 | $0 |
| 2021 | 2019 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44AG062014 | A Specialized Automatic Speech Recognition and Conversational Platform to Enable Socially Assistive Robots for Persons with Mild-to-Moderate Alzheimer's Disease and Related Dementia | 001 | 1 | NIH | 4/15/2021 | $0 |
| 2021 | 2018 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44NR017842 | A Protocol-Driven, Digital Conversational Agent at the Hospital Bedside to Support Nurse Teams and to Mitigate Delirium and Falls Risk | 000 | 1 | NIH | 2/11/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $2,058,301 ) |
| 2020 | 2020 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44NR017842 | A Protocol-Driven, Digital Conversational Agent at the Hospital Bedside to Support Nurse Teams and to Mitigate Delirium and Falls Risk | 000 | 3 | NIH | 12/20/2019 | $555,611 |
| 2020 | 2020 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44AG062014 | A Specialized Automatic Speech Recognition and Conversational Platform to Enable Socially Assistive Robots for Persons with Mild-to-Moderate Alzheimer's Disease and Related Dementia | 001 | 2 | NIH | 9/14/2020 | $1,502,690 |
| 2020 | 2019 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44NR017842 | A Protocol-Driven, Digital Conversational Agent at the Hospital Bedside to Support Nurse Teams and to Mitigate Delirium and Falls Risk | 001 | 2 | NIH | 12/31/2019 | $0 |
| 2020 | 2019 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44CA236253 | A Bedside Relational Agent to Improve Hematopoietic Cell Transplantation Outcomes in Cancer Patients | 000 | 1 | NIH | 9/9/2020 | $0 |
| 2020 | 2019 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44AG062014 | A Specialized Automatic Speech Recognition and Conversational Platform to Enable Socially Assistive Robots for Persons with Mild-to-Moderate Alzheimer's Disease and Related Dementia | 000 | 1 | NIH | 3/11/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,120,992 ) |
| 2019 | 2019 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44NR017842 | A Protocol-Driven, Digital Conversational Agent at the Hospital Bedside to Support Nurse Teams and to Mitigate Delirium and Falls Risk | 000 | 2 | NIH | 11/27/2018 | $546,049 |
| 2019 | 2019 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44CA236253 | A Bedside Relational Agent to Improve Hematopoietic Cell Transplantation Outcomes in Cancer Patients | 000 | 1 | NIH | 4/5/2019 | $224,945 |
| 2019 | 2019 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44AG062014 | A Specialized Automatic Speech Recognition and Conversational Platform to Enable Socially Assistive Robots for Persons with Mild-to-Moderate Alzheimer's Disease and Related Dementia | 000 | 1 | NIH | 6/25/2019 | $349,998 |
| 2019 | 2019 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44AG062014 | A Specialized Automatic Speech Recognition and Conversational Platform to Enable Socially Assistive Robots for Persons with Mild-to-Moderate Alzheimer's Disease and Related Dementia | 001 | 1 | NIH | 6/27/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $202,032 ) |
| 2018 | 2018 | CARE.COACH CORPORATION | 660 EL CAMINO REAL STE 210 | MILLBRAE | CA | 94030-2060 | SAN MATEO | USA | R44NR017842 | A Protocol-Driven, Digital Conversational Agent at the Hospital Bedside to Support Nurse Teams and to Mitigate Delirium and Falls Risk | 000 | 1 | NIH | 4/24/2018 | $202,032 |
|
|